G

ood morning, everyone, and how are you today? The middle of the week is here, which means your survival skills are intact — so far. To celebrate, and to stay on track, you may want to reach for a cup of stimulation. We have already enjoyed a mug of golden French toast, for those interested in a little experimentation. Now, though, the time has come to get busy. So here are a few items of interest to get you started. So dig in and have a smashing day. And one other thing — do keep us in mind if you run across anything intriguing. As always, we accept confidential stuff and enjoy hearing secrets …

Colorado is angling to become the latest state to adopt drug-pricing transparency legislation. The House passed a bill that requires drug makers to notify the state, health plans and pharmacy benefit managers when prices rise by more than 10 percent. And within 15 days after the end of each quarter, drug makers must also provide certain information to the health commissioner about price hikes and newly marketed specialty medicines. Following the passage, the bill was introduced in the state Senate.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy